Background: Homocysteinylated-heterogeneous nuclear ribonucleoprotein-E1 (hnRNP-E1) orchestrates a posttranscriptional RNA operon during folate deficiency.
SUMMARY
Although HPV16-transforms infected epithelial tissues to cancer in the presence of several cofactors, there is insufficient molecular evidence that poor nutrition has any such role. Because physiological folate deficiency led to the intracellular homocysteinylation of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and activated a nutrition-sensitive [homocysteine-responsive] posttranscriptional RNA operon that included interaction with HPV16 L2 mRNA, we investigated the functional consequences of folate deficiency on HPV16 in immortalized HPV16-harboring human (BC-1-Ep/SL) keratinocytes and HPV16-organotypic rafts.
Although homocysteinylated-hnRNP-E1 interacted with HPV16 L2 mRNA ciselement, it also specifically bound another HPV16 57-nucleotide poly(U)-rich cis-element in the early polyadenylation element (upstream of L2^L1 genes) with greater affinity. Together, these interactions led to a profound reduction of both L1 and L2 mRNA and proteins without effects on HPV16 E6 and E7 in vitro, and in cultured keratinocyte monolayers and HPV16-low folate-organotypic rafts developed in physiological low-folate medium. In addition, HPV16-low folate-organotypic rafts contained fewer HPV16-viral particles, a similar HPV16 DNA viral load, and a much greater extent of integration of HPV16 DNA into genomic DNA when compared to HPV16-high folateorganotypic rafts. Subcutaneous implantation of 18-day old HPV16-low folate-organotypic rafts into folate-replete immunodeficient mice transformed this benign keratinocyte-derived raft-tissue into an aggressive HPV16-induced cancer within 12 weeks.
Collectively, these studies establish a likely molecular linkage between poor folatenutrition and HPV16, and predict that nutritional folate and/or vitamin-B 12 deficiency---which are both common worldwide---will alter the natural history of HPV16-infections, and also warrant serious consideration as reversible co-factors in oncogenic transformation of HPV16-infected tissues to cancer.
Human papillomaviruses (HPV), which infect suprabasal keratinocytes and persist in differentiating epithelial cells of cutaneous, mucosal, and genital tissues, are causally implicated in several cancers as well as venereal and other skin warts (1) (2) (3) (4) . The Centers for Disease Control and Prevention 1 estimates that HPV causes almost all cervical cancer, and links HPV to about 50% of vulvar cancers, 65% of vaginal cancers, 35% of penile cancers, 95% of anal cancer, and up to 60% of oropharyngeal cancers. The prevalence of latent HPV infection is approximately 40% worldwide, and whereas 5-10% of infected women will develop squamous intraepithelial lesions, less than 1% will develop cervical cancer (5) . Among the various oncogenic HPV-types, HPV16 is the commonest agent that is responsible for an estimated one-half of all HPVassociated cancers worldwide. There are established co-factors that accelerate HPV-induced transformation of tissues to cancer. Among these co-factors-(early age at first intercourse, multiple partners, smoking, oral contraceptives, and reduced immunity with HIV/AIDS)-the role of poor folate nutrition has been suspected for three decades, but no molecular linkage with HPV has been identified. Nevertheless, because of limited non-surgical options for eradication of established HPV infection in cervical and other epithelial tissues, identification of any reversible cofactor (such as a nutritional deficiency) that can modulate the expression of HPV is eminently worthy of study.
Following epithelial cell division, HPVinfected daughter cells migrate superficially from the basal region and begin differentiation. Upon terminal differentiation in the granulosa and cornified layers of infected epithelia, vegetative viral DNA replication or amplification is induced followed by activation of viral late gene expression-encoding HPV viral capsid proteins L1 and L2 at a 20:1 ratio, respectively-with subsequent assembly and encapsidation of HPV DNA into infectious HPV virions (3, 6) . Although a comprehensive understanding of the precise molecular basis for the expression of L2 and L1 in differentiating cells is still incomplete, it has been known for over a decade that cellular hnRNP-E1 can interact with the 3'-coding region of HPV16 L2 mRNA (7) . Furthermore, by engineering HeLa cells to express L2, Collier et al (7) showed that transfection of hnRNP-E1 reduces expression of L2. However, it not clear if this interaction involves direct reduction of L2 mRNA translation and/or reduced stability of the mRNA-protein complex, or another mechanism, and if this occurs in cultured keratinocytes that can actively express all HPV genes. Moreover, the pathophysiologic context wherein hnRNP-E1 interacts with HPV16 RNA has also remained obscure.
Earlier we had determined that upregulation of folate receptors in cervical cancer cells during folate deficiency involved the binding of hnRNP-E1 to an 18-base cis-element in the 5'-untranslated region of folate receptor-α mRNA which triggered an increase in folate receptor biosynthesis at the translational level (8, 9) . Because this RNA-protein interaction was stimulated by homocysteine, which accumulates intracellularly during folate deficiency, this work established a link between perturbed folate metabolism and coordinated translational regulation of folate receptors (10) . Using purified components, we recently determined that the molecular mechanism of this posttranscriptional up-regulation of folate receptors during folate deficiency involves a concentration-dependent homocysteinylation of various cysteine residues within the [mRNA-binding] K-homology domains of hnRNP-E1, which likely leads to the sequential disruption of critical cysteine-S-S-cysteine bonds by the formation of multiple homocysteine-S-Scysteine mixed disulfide bonds in hnRNP-E1 (11) . This leads to a gradual unmasking of an underlying RNA-binding pocket in homocysteinylated-hnRNP-E1 that progressively increases its affinity for folate receptor-α mRNA cis-element preparatory to folate receptor upregulation. These data incriminated hnRNP-E1 as a physiologically relevant and sensitive candidate sensor of folate deficiency within cells (11) . And since diverse mRNAs (including rabbit 15-lipoxygenase, murine tyrosine hydroxylase and intermediate neurofilament-middle molecular mass, and HPV16 L2 mRNA) also interacted with this RNA-binding domain (7, 8) , we proposed that homocysteinylated-hnRNP-E1 was well positioned to orchestrate a nutrition-sensitive [homocysteine-responsive] posttranscriptional RNA operon in folate-deficient cells.
Because this research had uncovered unexpected connections between folate deficiency, homocysteine, hnRNP-E1, and HPV16 (7, 10, 11) , we determined the functional physiological consequence of folate deficiency to HPV16 viral capsid protein expression using a model of HPV16-harboring human keratinocytes [(HPV16)BC-1-Ep/SL cells] that expressed the full complement of HPV16 RNA when propagated as monolayers. Further extension of these studies to HPV16-organotypic rafts and additional animal studies suggest that folate deficiency is a likely (reversible) co-factor in HPV16-induced malignancies.
genome was first cloned into the pSPT19 vector with EcoRI on the 5'-end and HindIII on the 3'-end. The two oligonucleotides (5'-AAT TCT TTT  TTC TTT TTT ATT TTC ATA TAT AAT TTT  TTT TTT TGT TTG TTT GTT TGT TTT TTG-3'  and 5'-AGC TTA AAA AAC AAA CAA ACA  AAC AAA AAA AAA AAT TAT ATA TGA  AAA TAA AAA AGA AAA AAA-3') in a final volume of 500 l of binding buffer with 25 μM of L-homocysteine at 4C for 0.5 h. Bovine serum albumin (BSA), 0.1 g, was used as a control in place of hnRNP-E1 for background determination. The mixture was then filtered through a Microcon YM-30 column by centrifugation at 12,000 x g followed by three consecutive washes, each with 500 l binding buffer. The retentate containing RNA-protein complexes (150 l) was counted in a β-scintillation counter. Counts from samples containing hnRNP-E1 were recorded as total binding while counts from samples containing BSA reflected non-specific binding. The specific binding for each concentration of radioligand was determined by subtracting the non-specific binding from the results of total binding. The K D was calculated from a Scatchard plot (14) using GraphPad Prism 4 from GraphPad Software (San Diego, CA).
Effect of RNA interference of hnRNP-E1 mRNA on HPV16 L1 and L2 mRNA-Before the day of siRNA transfection, (HPV16)BC-1-Ep/SL-LF cells were trypsinized, counted, and plated in 6-well plates at 1.4 × 10 5 cells per well in 2.5 ml of F-LF medium, so that cells were 35-45% confluent after overnight culture. Cells were transfected with either 10 nM predesigned Stealth RNA (siRNA-hnRNP-E1/PCBP1) (15) or 10 nM scrambled negative stealth RNAi control (Invitrogen) using Lipofectamine RNAiMAX transfection reagent, as described (11) . Cells were trypsinized and harvested at 1, 2, and 3 days after transfection for qRT-PCR analysis of hnRNP-E1, hnRNP-E2, HPV L1, L2, E6 and E7 mRNA levels. In addition, the rate of biosynthesis of newly synthesized hnRNP-E1 was also determined in transfected cells (11) .
HPV16-organotypic raft cultures-Before development of HPV16-organotypic raft cultures, (HPV16)BC-1-Ep/SL cells were adapted to either high-folate F-medium (F-HF) or physiologically low-folate F-medium (F-LF) containing 10% FBS-which contributed 13.6 nM 5-methyltetrahydrofolate to the F-LF medium-for over 25 weeks. NIH 3T3 cells were likewise adapted to modified F-HF or F-LF media for over 10 weeks to ensure stable intracellular folate levels (10) . Before being placed on the raft, (HPV16)BC-1-Ep/SL-HF and (HPV16)BC-1-Ep/SL-LF cells were cultured on Mitomycin C-treated F-HF or F-LF NIH3T3 feeder layers, respectively.
To construct HPV16-organotypic rafts, rat tail type 1 collagen (3.71 mg/ml) (BD Biosciences, Two Oak Park, Bedford MA) was used to coat BD BioCoat inserts (6-well plates; 3 micron pore size). The remaining collagen was impregnated with either F-HF-or F-LF-adapted NIH3T3 (4.5 x 10 5 cells/ml) and plated on collagen-coated inserts, following which the collagen was allowed to contract in 10% FBS-containing F-HF or F-LF media, respectively, for 5 days at 37°C in a continuous CO 2 (5%) incubator. Then 50 μl of 1.4 x 10 6 cells/ml (7 x 10 4 cells) in keratinocyteplating media-[consisting of F-HF or F-LF media containing 0.5% FBS, insulin (5 mg/ml), cholera toxin (8.4 ng/ml), adenine (24 mg/ml), and hydrocortisone (0.4 mg/ml)]-were plated onto the collagen rafts. Four days after plating keratinocytes, the rafts were placed on two 1 square inch cotton pads (VWR Scientific, Media, PA) in a BD BioCoat Deep Well 6-well plate (Becton Dickinson Labware) to lift to the airliquid interface. The rafts were fed from below the insert with cornification media-[consisting of F-HF or F-LF media (containing 1.88 mM Ca 2+ ) supplemented with 10% FBS, insulin (5 mg/ml), cholera toxin (8.4 ng/ml), adenine (24 mg/ml), and hydrocortisone (0.4 mg/ml)]-every other day. Fourteen days after being lifted to the air-liquid interface, one part of the rafts were fixed in 4% formalin, embedded in 2% agar in 1% formalin followed by paraffin, and cut into 4 µm thick cross-sections; other parts of the rafts were used for RNA and DNA isolation or electron microscopic analysis.
Quantitative PCR (qPCR) for HPV16 viral load and integration-To prepare HPV16-organotypic raft total DNA for analysis of the HPV16 viral load by qPCR, four 18-day old HPV16-high folate-organotypic rafts as well as four HPV16-low folate-organotypic rafts were separately ground in 5 ml Dulbecco's phosphate buffered saline (D-PBS) with autoclaved sea sand (EMD Chemicals Inc, PA) using a mortar and pestle (Fisher Scientific). The resulting paste was clarified by centrifugation for 10 min at 4000 rpm in a refrigerated Beckman GPR centifuge. After discarding the pellets, raft total DNA (including genomic and viral DNA) was extracted from the suspension using the NucleoSpin® Blood kit (Macherey-Nagel GmbH & Co., Germany). Briefly, the supernatant was incubated at 70°C for 15 min in lysis buffer containing proteinase K, and after binding to the silica column, and washing, the DNA was eluted in 100 μl elution buffer. The DNA was stored at -20°C until use for qPCR.
DNA copy numbers of HPV 16 E6, E7, E2, and GAPDH in 50 ng raft total DNA were measured by qPCR in triplicate using the Platinum Quantitative PCR SuperMix-UDG kit (Invitrogen) and the ABI 7900 HT detection system (Applied Biosystems). Sequence-specific primers for GAPDH, HPV16 E6 and E7 were designed using the Invitrogen customer primer design online system; these sequences are shown in the supplemental Methods (under Quantitative RT-PCR (qRT-PCR), primers, and validation). The oligonucleotide primers used in the measurement of HPV16 DNA integration into genomic DNA were obtained from Integrated DNA Technologies (Coralville, IA). The assay for integration evaluated the ratio between HPV16 E2 DNA and HPV16 E6 DNA (16) . An altered E2/E6 ratio is an established parameter that reflects integration into cellular DNA. The principle is that a unique region of the E2 open reading frame is most often deleted during HPV16 integration. This is targeted by one set of PCR primers and a probe, and another set targets the E6 open reading frame. In episomal form, both targets should be equivalent, while in integrated forms, the copy numbers of E2 would be less than those of E6. The primers for E2 were as follows. Probe: 5'-6-FAM/CAC CCC GCC /ZEN/ GCG ACC CAT A/3IABkFQ/-3'; forward primer: 5'-AAC GAA GTA TCC TCT CCT GAA ATT ATT AG-3'; and reverse primer: 5'-CCA AGG CGA CGG CTT TG-3'. (6-FAM is 6-carboxyfluorescein; ZEN, an internal quencher 9 bases from the 5' fluorophore, is an undisclosed proprietary agent; and IABkFQ is Dark Quencher Iowa Black® FQ). The primers for E6 were as follows. Probe: 5'-6-FAM/ CAG GAG CGA /ZEN/ CCC AGA AAG TTA CCA CAG T/3IABkFQ/-3'; forward primer: 5'-GAG AAC TGC AAT GTT TCA GGA CC-3'; and reverse primer: 5'-TGT ATA GTT GTT TGC AGC TCT GTG C-3'. The probe to primer ratio in these experiments was 1:2.
Standard curves of HPV16 E6, E7, and E2 were generated for measurement of viral DNA copies, and standard curves of GAPDH were generated for normalizing the input DNA content. Briefly, standard curves were generated using 10-fold dilutions of HPV16 plasmid or amplified GAPDH DNA (from 10 1 to 10 7 copies). Amplifications were carried out using the ABI HT7900 sequence detection system; the cycle conditions for qPCR were 50°C for 2 min, 95°C for 2 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 60 sec. The actual copy numbers of HPV E6, E7, E2, and GAPDH were determined by qPCR using 50 ng raft total DNA, and were then normalized by the copy numbers of GAPDH.
The viral load was calculated by dividing the normalized copy number of HPV16 E6 DNA by 50 ng of raft total DNA and expressed as copies of HPV16 E6 DNA per ng raft total DNA, according to the formula by Carcopino et al (17) , with the exception that we used the 'ng of raft total DNA' in place of 'cells' in that formula. The amount of integrated HPV16 E6 DNA was calculated by subtracting the copy number of HPV16 E2 episomal DNA from the total copy number of HPV16 E6 DNA (episomal and integrated). The percentage of HPV16 DNA that was integrated into genomic DNA was then determined by dividing the integrated HPV16 E6 DNA copy number by total HPV16 E6 DNA copy number, and the result multiplied by 100.
Model Previous methods used to implant fragments of HPV-infected human foreskins under the skin of mice (18, 19) , were modified for implantation of either HPV16-high folate-or -low folate-organotypic rafts in all three species of immunodeficient mice. Briefly, 18-day old HPV16-high folate-organotypic rafts and HPV16-low folate-organotypic rafts were washed with sterile D-PBS, cut into 5x5x1 mm pieces, and transported in Petri dishes at 4°C to the animal facility in either serum-free F-HF or F-LF medium, respectively. All mice remained deeply anesthetized before and throughout the surgical procedure. Under sterile conditions, a 1 cm midflank skin incision was made perpendicular to the spine below the costophrenic angle with scissors, and a subcutaneous pocket was created using a blunt forceps. A fragment from either a HPV16-high folate-or a low folate-organotypic raft was then inserted subcutaneously and repositioned in a top-to-bottom orientation to facilitate angiogenesis of the raft from below, and the incision was closed with a surgical clip. After postoperative recovery from anesthesia, the mouse was transferred to a regular cage. The surgical clips were removed one week after surgery without anesthesia. The mice were then observed twice a week for tumor growth. Once tumors were established, measurements were taken on a regular basis (18, 19) . Quantification of tumor growth was made using the recently described formula (20) .
Following the transformation of an HPV16-low folate-organotypic raft into an aggressive tumor in a Beige Nude XID mouse, fragments (3x3x2 mm) from this primary tumor were transplanted into other immunodeficient mice. Following growth of these secondary tumors, additional immunodeficient mice were transplanted with fragments from these secondary tumors, and the subsequent growth of tertiary tumors was also monitored.
See tissue histology, immunohistochemistry, and fluorescence microscopy, western blot analysis: electron microscopy.
RESULTS
Homocysteine-responsiveness of the interaction of HPV16 L2 mRNA and purified recombinant GST-hnRNP-E1 in vitroBecause incubation of L-homocysteine with purified recombinant GST-hnRNP-E1 led to a covalent interaction with the protein (11), we tested the effect of homocysteinylated-hnRNP-E1 in binding to HPV16 L2 mRNA and in altering its translation in vitro. Fig. 1A demonstrates a dose-dependent increase in generation of HPV16 L2 RNA-bound GST-hnRNP-E1 protein complexes with increasing physiologically relevant concentrations of L-homocysteine that achieved saturability, and which exhibited a super-shift only with specific anti-hnRNP-E1 antiserum (9) on gel-shift assays. Because HPV16 L2 single-stranded sense DNA did not interact with L-homocysteine-derivatized GST-hnRNP-E1 (Fig. 1B) , the locus for interaction between homocysteinylated-hnRNP-E1 and HPV16 L2 was at the level of an RNA-protein interaction. As earlier noted for the binding interaction of hnRNP-E1 and folate receptor- mRNA cis-element, there was a progressive increase in binding affinity between purified recombinant GST-hnRNP-E1 and HPV16 L2 RNA cis-element as the concentration of Lhomocysteine increased in the reaction mixture; thus, there was a reduction in K D from basal values of 1.6 nM to 0.5 nM at 50 µM L-homocysteine.
Endogenous hnRNP-E1 is found in small quantities in the reticulocyte lysate of the translation reaction mixture (9, 11) . So after quenching the excess (4.1 mM) -mercaptoethanol extant in the commercial translation kit by 2-mM N-ethyl maleimide, the addition of increasing physiologically relevant concentrations of Lhomocysteine led to a dose-dependent quenching of HPV16 L2 protein synthesis (Fig. 1C, lanes 3-7) ; these inhibitory effects were not due to premature degradation of HPV16 L2 mRNA during in vitro translation (supplemental Fig. S2 ). In addition, the in vitro translation of HPV16 L2 was mediated by hnRNP-E1 because there was a dose-dependent reduction in [ 35 S]HPV16 L2 protein (Fig. 1D , lanes 2-5) upon the addition of increasing concentration of purified recombinant GST-hnRNP-E1, which was reversed in a dosedependent manner by the addition of increasing concentrations of anti-hnRNP-E1 antiserum to the reaction mixture (Fig. 1D, lanes 6-10) . By contrast, increasing concentrations of non-immune serum (Fig. 1E , lanes 8-10) had no effect in reversing the inhibitory effect of purified recombinant GST-hnRNP-E1 on HPV16 L2 synthesis. Moreover, an unrelated protein like bovine serum albumin (Fig. 1F , lanes [6] [7] [8] 
Determination of the thiol content of (HPV16)BC-1-Ep/SL-HF and (HPV16)BC-1-Ep/SL-LF cells and effects on RNA-protein interaction-(HPV16)BC-1-Ep/SL
cells propagated long-term in high-folate (F-HF) and physiological low-folate (F-LF) media had comparable cell doubling-times of 29.5 h and 30 h, respectively. Simultaneous measurements of various intracellular thiols in (HPV16)BC-1-Ep/SL-HF cells that were shifted to F-LF media over 12 weeks confirmed a progressive increase in only homocysteine to nearly 3 times more than baseline, from 7-to ~20-M by 12 weeks (Fig. 2  A-D) . This suggested that the low-folate environment, which led to the accumulation of more homocysteine, could influence the interaction of HPV16 L2 RNA cis-element and endogenous hnRNP-E1. Because (HPV16)BC-1-Ep/SL-HF expressed the full complement of HPV16 RNA (supplemental Fig. S1 , discussed below), we compared the expression of HPV16 RNA between (HPV16)BC-1-Ep/SL-HF and (HPV16)BC-1-Ep/SL-LF cells.
Measurement of various HPV16 RNA in (HPV16)BC-1-Ep/SL-HF cells.
In order to validate the qRT-PCR method that was used to measure small quantities of HPV16 RNA in (HPV16)BC-1-Ep/SL-HF cells, we determined individual standard curves between target RNA (HPV16 L2, L1, E6, E7, as well as human folate receptor-, hnRNP-E1, and reference RNA (GAPDH), which demonstrated comparable high efficiency of amplification of the target RNA and the reference RNA. Supplemental Fig. S1 demonstrates qRT-PCR profiles with the standard curve of HPV16 L1 and GAPDH (Fig. S1A and B) , as well as HPV16 L2 and GAPDH ( (Fig. 2G) . However, because there was no interaction between hnRNP-E1 and single-stranded HPV16 L2 DNA (Fig. 1B) , this suggested that the reduction in HPV16 L2 RNA (and HPV16 L1 RNA), following either stable propagation of cells in low-folate media (Fig. 2E) or following transfection of hnRNP-E1 (Fig. 2G) , was through effects on a putative locus that was distinct from HPV16 L2 RNA. Moreover, the greater reduction of HPV16 L1 and L2 in low-folate cells (Fig. 2E and F) suggested that this locus was responsive to homocysteine-derivatized hnRNP-E1.
Because extracellular L-homocysteine can enter cultured human cells by an active cysteine transporter system (21), we determined if abruptly increasing the concentration of L-homocysteine in media led to acute changes (over 2 h) in HPV16 L1 and L2 in (HPV16)BC-1-Ep/SL-HF cells. Fig.  2H confirmed a dose-dependent reduction in intracellular HPV16 L1 and L2 RNA when (HPV16)BC-1-Ep/SL-HF cells were exposed to increasing concentrations of L-homocysteine. Since effects were also noted at 12.5-and 25-M of L-homocysteine, this suggested that the interaction of endogenous hnRNP-E1 and HPV16 RNA occurred within cells at physiologically appropriate concentrations of homocysteine that would be found even in mild folate deficiency.
Interaction of hnRNP-E1 with a HPV16 57-nucleotide poly(U)-rich cis-elementA potential candidate locus to mediate the profound dual reduction of HPV16 L2 and L1 expression in (HPV16)BC-1-Ep/SL-LF cells was a 57-nucleotide RNA domain in the early polyadenylation element of the HPV16 genome (Fig. 3A) . This domain, which is located upstream of L2^L1 genes, can control the expression of L2 and L1 genes (13) , and is also known to bind other members of the hnRNP family (13) . Fig. 3B shows that the addition of increasing concentrations of Lhomocysteine to a mixture of purified recombinant GST-hnRNP-E1 and this putative HPV16 57-nucleotide RNA cis-element led to progressively greater RNA-protein complex signals in a dosedependent, saturable manner. There was a supershift of the RNA protein signal with antihnRNP-E1 antibody (in Lane 9) with no supershift with non-immune serum (not shown), which confirmed the presence of hnRNP-E1 within the RNA-protein complexes. By contrast, there was no interaction between homocysteinylated-hnRNP-E1 and HPV16 57-nucleotide poly(T)-rich singlestranded sense DNA (Fig. 3C) , confirming that the HPV16 57-nucleotide RNA domain only interacted with homocysteinylated-hnRNP-E1.
To further evaluate the specificity of the HPV16 57-nucleotide RNA cis-element for binding purified recombinant GST-hnRNP-E1 in the presence of L-homocysteine, we induced specific mutations within the HPV16 57-nucleotide RNA cis-element (Fig. 3D ). As shown in Fig. 3E , although there was interaction between purified recombinant GST-hnRNP-E1 and some mutations (pM1, and pM2) similar to wild-type (pWT) HPV16 57-nucleotide RNA cis-element in the presence of 50 M L-homocysteine, there was no interaction when an additional mutation (pM3) was introduced, confirming the specificity of this RNA-protein interaction.
To determine if there was physiological interaction of hnRNP-E1 with this HPV16 57-nucleotide cis-element within cells in response to homocysteine, we captured these RNA-protein complexes in (HPV16)BC-1-Ep/SL-HF cells as a function of the addition of physiologically relevant concentrations of L-homocysteine, as recently described (11) . This was achieved by first crosslinking the endogenous RNA-protein complexes with UV light, followed by specific immunoprecipitation using anti-hnRNP-E1 antiserum. Then after cleaving unprotected RNA that was not in close apposition to the immunoprecipitated hnRNP-E1 protein, the HPV16 57-nucleotide RNA cis-element (as well as other RNA cis-elements) that remained crosslinked to hnRNP-E1 were released by proteolysis of hnRNP-E1. Following this step, equivalent amounts of the remaining RNA were tested for the capacity to hybridize under stringent conditions with [ 35 S]-labeled antisense probe to the HPV16 57-nucleotide RNA cis-element using slot-blot hybridization analysis. As shown in Fig. 3F , lanes 2-4, there was a L-homocysteine-induced dosedependent increase in signal from hybridization with HPV16 57-nucleotide RNA cis-element antisense probe when compared to control samples to which L-homocysteine was not added (Fig. 3F,  lane 1) . Moreover, the specificity of this hybridization was shown by the lack of hybridization signal (Fig. 3F, lane 6) using the HPV16 57-nucleotide RNA cis-element sense probe. The positive controls using denatured pYS57 (Fig. 3F, Fig. 4D , the measured mRNA levels of pCAT control were not significantly changed while the mRNA levels of [p57-CAT] were slightly increased (up to 1.5-fold) with addition of 0-, 10-, and 50-μM L-homocysteine. These data supported the likelihood that the observed inhibitory effects of L-homocysteine on the [HPV16 57-nucleotide RNA cis-element-CAT construct]-related CAT activity (Fig. 4C) were at a translational level.
Taken together, these results suggested that interaction of endogenous homocysteinylatedhnRNP-E1 with the HPV16 57-nucleotide RNA cis-element in (HPV16)BC-1-Ep/SL-LF cells inhibited downstream genes, and could explain, in part, the observed reduction in levels of HPV16 L2 and L1 mRNA and protein (Fig. 2E and F) .
Comparison Because of comparably high basal concentrations of cysteine and homocysteine in (HPV16)BC-1-Ep/SL-LF cells ( Fig. 2A and B) , we determined if there were subtle differences in binding affinity between the HPV16 57-nucleotide RNA cis-element and purified recombinant GSThnRNP-E1 protein at equimolar (15 M) concentrations of L-cysteine and L-homocysteine. Table 1 (Fig. 4A) .
Effect of RNA interference of hnRNP-E1 mRNA on HPV16 L1 and L2 mRNA in (HPV16)BC-1-Ep/SL-LF cells-RNA interference (RNAi) revealed that siRNA elicited maximal effect in reducing hnRNP-E1 mRNA by over 90% within one day, which persisted over the ensuing 3 days (Fig. 5A ). This siRNA had no effect on the closely related hnRNP-E2 mRNA (11) . Evaluation of the biosynthetic rate of newly synthesized hnRNP-E1 protein 48 h after RNAi of hnRNP-E1 mRNA revealed a significant reduction when compared to controls using scrambled RNA (Fig.  5B) . This predicted that RNAi of hnRNP-E1 mRNA could affect the level of HPV16 L2 and L1 in (HPV16)BC-1-Ep/SL-LF cells. As shown in Fig. 5C , there was no change in HPV16 E6 and E7 mRNA over the subsequent three days in (HPV16)BC-1-Ep/SL-LF cells following RNAi of hnRNP-E1 mRNA; this was consistent with a lack of effect of homocysteinylated-hnRNP-E1 on E6 and E7 mRNA and protein (Fig 2) . By contrast, there was a significant time-dependent increase in levels of HPV16 L2 and L1 mRNA over the subsequent 3 days (Fig. 5C ). This reflected an escape from the inhibitory effects of interaction of HPV16 RNA with homocysteinylated-hnRNP-E1 protein, and confirmed the specificity of effects of hnRNP-E1 on HPV16 L1 and L2. Table 2 , the rate of biosynthesis of L2 and L1 RNA transcripts were significantly decreased in (HPV16)BC-1-Ep/SL-LF when compared to (HPV16)BC-1-Ep/SL-HF cells. Table 2 also shows the rate of degradation of L2 and L1 RNA in (HPV16)BC-1-Ep/SL-LF cells was significantly increased when compared to (HPV16)BC-1-Ep/SL-HF cells. Together, these data were consistent with a conclusion that the binding of homocysteinylated-hnRNP-E1 to the HPV16 57-nucleotide poly(U)-rich cis-element led to a reduction in the rate of biosynthesis of both L2 and L1 mRNA, as well as an increase in degradation of these mRNA transcripts, and these events likely contributed to the net reduction in L2 and L1 RNA levels in (HPV16)BC-1-Ep/SL-LF cells (Fig. 2). [Because there was no interaction between homocysteinylated-hnRNP-E1 and single stranded HPV16 DNA, the term 'biosynthesis of RNA' used here refers to rate of formation of mature HPV16 L2 and L1 RNA].
Comparison of the rates of biosynthesis and degradation of HPV L1 and L2 mRNAs and HPV16 L1 and L2 proteins in (HPV16)BC-1-Ep/SL-HF and (HPV16)BC-1-Ep/SL-LF cells-As shown in
The protein biosynthetic rates of GAPDH and L1 were comparable in both (HPV16)BC-1-Ep/SL-LF and (HPV16)BC-1-Ep/SL-HF cells (Table 3) . However, the rate of protein biosynthesis of L2 in (HPV16)BC-1-Ep/SL-LF cells was about one-half the value obtained with (HPV16)BC-1-Ep/SL-HF cells. These data are compatible with Fig. 1 where the independent interaction of L2 mRNA and homocysteinylatedhnRNP-E1 led to reduction in synthesis of L2 in vitro. In addition, the rate of biosynthesis of hnRNP-E1 was lower in (HPV16)BC-1-Ep/SL-LF cells (Table 1) . Thus, although the biosynthetic rate of hnRNP-E1 in low-folate media was lower, (consistent with lower net amount of hnRNP-E1, as noted in Fig. 2F ), the accumulation of nearly 3-fold more intracellular homocysteine could result in the homocysteinylation of endogenous hnRNP-E1 leading to efficient reduction in HPV16 L1 and L2 via effects on the HPV16 57-nucleotide ciselement and the L2 mRNA cis-element.
The rates of protein degradation of hnRNP-E1 and GAPDH were comparably unchanged in (HPV16)BC-1-Ep/SL-HF and (HPV16)BC-1-Ep/SL-LF cells (Table  4) . However, the rate of degradation of HPV16 L1 protein was 1.7-fold higher while that of HPV16 L2 protein was 2.4-fold higher in (HPV16)BC-1-Ep/SL-LF cells when compared to (HPV16)BC-1-Ep/SL-HF cells. Thus, the increased degradation of HPV16 L2 and L1 protein that was independent of effects on HPV16 L2 and L1 RNA degradation could be yet another contributor to the net reduction in L2 and L1 in (HPV16)BC-1-Ep/SL-LF cells.
Collectively, these biosynthesis and degradation studies at the mRNA and protein level (Table 2-4) demonstrated that (HPV16)BC-1-Ep/SL-LF cells exhibited (i) reduced rates of biosynthesis of both HPV16 L1 and L2 RNA, (ii) increased degradation rates of both HPV16 L1 and L2 RNA, (iii) reduced rates of biosynthesis of HPV16 L2 protein, and (iv) increased rates of degradation of both HPV16 L1 and L2 proteins when compared to (HPV16)BC-1-Ep/SL-HF cells. Taken together, the combination of these changes can explain the basis for the profound reduction of HPV16 L1 and L2 in folate-deficient (HPV16)BC-1-Ep/SL-LF cells.
Comparison of HPV16 viral capsid proteins, viral load, viral particles, and viral integration in HPV16-organotypic rafts developed
in either low-folate or high-folate media-In order to define the physiological consequences of the HPV16 RNA-hnRNP-E1 interaction, we switched studies from the use of (HPV16)BC-1-Ep/SL keratinocytes propagated as monolayers to (HPV16)BC-1-Ep/SL-keratinocyte-derived HPV16-organotypic rafts (12) . In this model, HPV16-harboring keratinocytes were stimulated to differentiate so that the HPV16 life cycle would be operative (3,6); HPV16 L1 and L2 would be generated late in the HPV16 life cycle within [superficial] differentiated layers of these HPV16-organotypic rafts; and complete 55 nm HPV16 viral particles would be found in the topmost layers of these rafts. Accordingly, (HPV16)BC-1-Ep/SL-HF and -LF cells were developed into HPV16-high folate-and -low folate-organotypic rafts, respectively. The use of a slightly higher concentration of folate (13.6 nM 5-methyltetrahydrofolate) in HPV16-low folateorganotypic rafts (as opposed to 6.8 nM 5-methyltetrathydrofolate that was used for (HPV16)BC-1-Ep/SL-LF monolayers) allowed for better quality rafts to be generated that did not compromise the capacity for differentiation (supplemental Fig. S3 ). Differentiation in HPV16-high folate-and -low folate-organotypic rafts was confirmed using histology (supplemental Fig. S3A and S3B) ; immunofluorescence (supplemental Fig. S3C and  S3D ) with filaggrin-a filament-associated protein that binds to keratin fibers in epithelial cells and is a bona fide differentiation marker (22) ; immunohistochemistry (supplemental Fig. S3F ,G and S3I,J); and Western blots (supplemental Fig  S3E and S3H ) to measure keratin 10 and filaggrin. Although there were subtle architectural abnormalities arising from disordered proliferation in the basal layers of HPV16-low folateorganotypic rafts when compared to HPV16-high folate-organotypic rafts, this was comparable to that seen in folate-deficient murine fetal epithelial tissues (23) where differentiation of keratinocytes in the skin was also retained.
As noted with monolayers of HPV16-harboring keratinocytes in low-folate media (Fig.  2) , there was a marked reduction of HPV16 L1 and L2 mRNA in HPV16-low folate-organotypic rafts ( Fig. 6A and B) without changes in HPV16 E6 or E7 RNA (Fig. 6C and D) when compared to HPV16-high folate-organotypic rafts. In addition, there were no differences in HPV16 DNA viral load when comparing HPV16-high folate-andlow folate-organotypic rafts (Fig. 6E and F) indicating no perturbation of the amplification step in the HPV16 life cycle of these rafts. The inability of HPV16-low folate-organotypic rafts to generate HPV16 L1 and L2 viral capsid proteins despite a large amount of amplified HPV DNA predicted a net reduction in the number of HPV16 55 nm viral particles when compared to HPV16-high folate-organotypic rafts. This was confirmed by electron microscopy of the topmost differentiated layers of HPV16-high folateorganotypic rafts (Fig 6G and H) and HPV16-low folate-organotypic rafts (Fig. 6I and J) . The arrowheads point to several large clumps of viral particles in the magnification of X4,800 frame of HPV16-high folate-organotypic rafts (Fig. 6G) and a higher magnification of X68,000 of a boxed square from this frame is shown in Fig. 6H , where an abundance of 55 nm HPV16 viruses were seen. This sharply contrasts with comparable magnification views from HPV16-low folateorganotypic rafts, which exhibited a marked reduction of clumps of viruses (arrowheads in the magnification of X4800 frame; Fig 6I) . A boxed square from Fig. 6I that was magnified in Fig. 6J revealed 55 nm viruses, confirming that differentiation of HPV16-low folate-organotypic rafts was not compromised; however, the net number of these viral particles was less than that in HPV16-high folate-organotypic rafts (compare frames Fig. 6I and G) .
Because of this significant discordance between HPV16 DNA viral load and number of actual HPV16 viral particles observed on electron microscopy in HPV16-low folate-organotypic rafts, we investigated if there was a greater degree of integration of these apparently 'capsid-less' HPV16 DNA into genomic DNA. The method to determine the extent of integration of HPV16 DNA into genomic DNA was based on comparative measurement of the absolute values of the HPV16 E2 and E6 open reading frames in DNA samples from HPV16-high folate-and -low folate-organotypic rafts. In episomal form, the ratio of E2 to E6 is 1. However, ratios of E2 to E6 of less than 1 indicate the presence of both integrated and episomal forms. This is because the E2 primers and probe locations were selected to recognize the E2 hinge region, which is the part of the E2 open reading frame that is most often deleted upon HPV16 viral integration into cellular DNA (16, 24) . Fig. 6K depicts the data on HPV16 E6 DNA copies/ng raft total DNA, whereas Fig.  6L shows HPV16 E2 DNA copies/ng raft total DNA. When compared to HPV16-high folateorganotypic rafts, the HPV16-low folate-organotypic rafts exhibited a very low E2/E6 ratio. Thus, low-folate rafts contained ~88% HPV16 DNA integration into genomic DNA when compared to ~34% in high-folate rafts (Fig. 6M) (Fig. 7A ) developed in one of the two Beige Nude XID mice implanted with a fragment of an HPV16-low folate-organotypic raft (which contained 88% HPV16 DNA integration into cellular DNA). This tumor grew steadily over the next two weeks to 2 cm 3 but then rapidly increased in size over the next 10 days to 10 cm 3 , which mandated euthanasia. On light microscopy, histological evaluation of cells revealed a high nuclear:cytoplasmic ratio with an open chromatin, mitotic figures, and significant angiogenesis (Fig. 7B) . We could also identify viral particles within the tumor on electron microscopy ( Fig. 7C and D) . By contrast, there was no growth in HPV16-high folate-organotypic rafts implanted subcutaneously in 2 other Beige Nude XID mice. Neither was there growth of HPV16-organotypic rafts propagated in either lowfolate or high-folate amongst the other two species of Athymic Nude or SHrN TM SCID mice. We then tested whether subcutaneous transplantation of a small fragment of the HPV16-low folateorganotypic raft-derived primary tumor could grow in other folate-replete immunodeficient mice. The results revealed that rapidly growing secondary tumors developed in all 3 Beige Nude mice and in one out of one Athymic Nude mouse within 2 weeks. Furthermore, a fragment from a secondary tumor from a Beige Nude XID mouse also developed into a tertiary tumor within 2 weeks when implanted in SHrN TM SCID mice. One example is shown in Fig. 7E , and the growth profile of 4 such tumors in SHrN TM SCID mice is shown in Fig. 7F . Of additional significance, all tumors expressed HPV16 E6 and E7 as well as L1 and L2 proteins, as noted in the original tumor (Fig. 7G, lane 1) and in secondary tumors that developed in Beige Nude XID and Athymic Nude mice (Fig. 7G, lane 2-3, respectively) , thereby pointing to the HPV16 origin of the tumors. Histological evaluation of tertiary tumors revealed a monotonous population of cells with a high nuclear-cytoplasmic ratio and several mitotic figures (Fig. 7H) . Thus, the growth characteristics of this tumor fulfilled all criteria for an aggressive HPV16-derived cancer in that it could be transplanted, and re-transplanted over two generations of mice, and also retained expression of HPV16-oncogenes. Therefore, these studies showed that an 18-day old HPV16-low folateorganotypic raft had the capacity to be transformed into a high-grade malignant cancer within only 12 weeks, provided the host was severely immunodeficient. Taken together, these findings are consistent with the probability that folate deficiency functioned as a co-factor in HPV16-induced carcinogenesis.
DISCUSSION
This report provides mechanistic insight into the functional consequences of linkage involving folate deficiency, homocysteine, hnRNP-E1, HPV16 RNA, HPV16 DNA integration into genomic DNA, and HPV16-induced cancer in mice. Although homocysteinylated-hnRNP-E1 bound to HPV16 L2 mRNA and decreased its translation in vitro (Fig. 1) , this interaction could not entirely explain the observation of a very significant co-reduction of HPV16 L1 mRNA and protein that was identified in HPV16 harboring BC-1-Ep/SL-LF keratinocytes, which were stably propagated as monolayers in physiologically low-folate media (Fig. 2) . However, the interaction of homocysteinylated-hnRNP-E1 with the HPV16 57-nucleotide poly(U)-rich cis-element in the upstream early polyadenylation element of the HPV16 genome (13) was an attractive possibility to explain this observation for three reasons: (i) Deletion of this domainwhich is upstream of overlapping L2^L1 genes in the HPV16 genomereduced utilization of the HPV16 early polyadenylation signal resulting in read-through into the HPV16 late region and increased production of L1 and L2 mRNAs (13); therefore we reasoned that the binding of hnRNP-E1 to this region could reduce L2 and L1. (ii) This domain binds other members of the hnRNP family, including hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein (13) ; and (iii) earlier we purified hnRNP-E1 using poly(U)-Sepharose affinity chromatography (9) , suggesting that hnRNP-E1 would bind the HPV16 57-nucleotide poly(U)-rich cis-element. Subsequent studies on the binding of purified recombinant GST-hnRNP-E1 to HPV16 57-nucleotide poly(U)-rich cis-element in the presence of physiological concentrations of L-homocysteine, as well as mutation studies involving this cis-element, indicated the specificity and importance of this interaction (Fig. 3) . Subsequent CAT reporter studies (Fig. 4) predicted that a reduction in translation of the downstream sequences of HPV16 L2^L1 mRNA following the interaction of HPV16 57-nucleotide RNA cis-element with homocysteinylated-hnRNP-E1 would negatively impact on net protein levels in (HPV16)BC-1-Ep/SL-LF cells, which contain more homocysteine; this was experimentally demonstrated (Table 3) . Taken together, the dual interaction of homocysteinylated-hnRNP-E1 with HPV16 L2 mRNA and the HPV16 57-nucleotide RNA cis-element was likely responsible for the reduced levels of HPV16 L2 and L1 mRNA and protein in (HPV16)BC-1-Ep/SL-LF cells when compared to (HPV16)BC-1-Ep/SL-HF cells (Fig.  2) . Because there was a greater affinity of purified recombinant GST-hnRNP-E1 for the HPV16 57-nucleotide RNA cis-element than the HPV16 L2 mRNA, as well as a greater affinity of purified recombinant GST-hnRNP-E1 for the HPV16 57-nucleotide RNA cis-element in the presence of Lhomocysteine when compared to equimolar concentrations of L-cysteine (Table 1) , it appears that the interaction of homocysteinylated-hnRNP-E1 with the HPV16 57-nucleotide RNA ciselement in the upstream early polyadenylation element may be the more important physiological interaction within HPV16-harboring keratinocytes. The direct link between L-homocysteine in inducing the binding of hnRNP-E1 to the HPV16 57-nucleotide RNA cis-element was demonstrated by capture of these intracellular RNA-protein complexes as a function of the concentration of Lhomocysteine added to (HPV16)BC-1-Ep/SL-HF cells (Fig. 3F) . These studies required us to separate these complexes from other complexes that could also arise following the interaction of homocysteinylated-hnRNP-E1 with other mRNA cis-elements that share common poly(rC)-or poly(U)-rich sequences signatures, which also allows them to also bind to hnRNP-E1 under these conditions (7, 10, (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . Because hnRNP-E1 may have cross-linked some of these other mRNA (in addition to HPV16 57-nucleotide RNA ciselement) in cells containing higher-than-basal concentrations of L-homocysteine, we employed a similar strategy that was recently employed to detect folate receptor- mRNA ciselementhnRNP-E1 complexes (11) . Accordingly, we tested equal amounts of small RNA fragments that were released from endogenous [immunoprecipitated] homocysteinylated-hnRNP-E1 for the capacity to hybridize under stringent conditions with antisense probe to the HPV16 57-nucleotide RNA cis-element. Our results, which revealed progressively increased hybridization signals, clearly reflected the capture of HPV16 57-nucleotide RNA cis-element-bound hnRNP-E1 protein complexes within cells as a function of increasing intracellular L-homocysteine concentrations that mimicked various grades of physiological folate deficiency (Fig. 3F) .
The interaction of homocysteinylatedhnRNP-E1 with poly(rC)-rich HPV16 L2 mRNA and HPV16 57-nucleotide poly(U)-rich sequences, but not with corresponding poly-T sequences (Fig.  1B) , suggests that the decreased HPV16 L1 and L2 mRNA levels observed in low-folate cells is not explained by altered rates of DNA transcription. However, it is possible that posttranscriptional splicing of newly-transcribed heterogeneous nuclear pre-mRNA may have been affected upon binding by homocysteinylatedhnRNP-E1; this is because earlier studies demonstrated that the splicing in vitro of a mRNA precursor (pre-mRNA) was inhibited by a monoclonal antibody to hnRNP C proteins (35) . This antibody inhibits an early step of the reaction: cleavage at the 3' end of the upstream exon and the formation of the intron lariat. This finding is relevant since Schwartz's laboratory demonstrated (13) that the HPV16 57-nucleotide poly(U)-rich sequence is also bound by hnRNP C1 (just like homocysteinylated-hnRNP-E1 under physiologic conditions). Thus, it is possible that interaction of homocysteinylated-hnRNP-E1 with the HPV16 57-nucleotide poly(U)-rich pre-mRNA led to interference with pre-mRNA processing resulting in the reduced L1 and L2 mRNA biosynthetic rates (Table 2 ). Our studies also demonstrated reduced stability (increased rate of degradation of mRNA) of HPV16 L2 and L1 mRNA (Table 2) , which explained, in part, the reduced L1 and L2 mRNA measured in low-folate cells (Fig. 2) . Because the HPV DNA of both L2 and L1 overlap, it requires posttranscriptional splicing to release L2 from L1 mRNA. So it is possible that the observed increased L2 and L1 mRNA degradation rates (that was measured in minutes) may have occurred before the splicing event, since the data on the rate of reduction of both mRNAs was relatively rapid when compared to the other measured metabolic parameters in low-folate cells (Table 2 ). It is possible that additional binding of homocysteinylated-hnRNP-E1 to the 3'-coding region of HPV16 L2 RNA in the L2^L1 transcript before the splicing event that separates these overlapping L2^L1 mRNA (13) favors degradation of these unspliced L2^L1 transcripts (as noted by RNA-degradation measurements in (HPV16)BC-1-Ep/SL-LF cells in Table 2 ). Despite this, the level of HPV16 L2 mRNA was slightly lower than HPV16 L1 mRNA in lowfolate cells (Fig. 2E ). This can be partly explained by independent direct binding of homocysteinylated-hnRNP-E1 to HPV16 L2 mRNA (Fig. 1) , which could have further contributed to its reduction (after splicing) in lowfolate cells. Moreover the relatively greater reduction in HPV16 L2 than L1 protein expression can be explained by the additional direct effect of homocysteinylated-hnRNP-E1 in independently reducing the translation of HPV16 L2 mRNA (Fig.  1) .
Because hnRNP-E1 has multiple effects within cells (11, 36) , prolonged RNA interference posed the risk of additional off-target effects. Moreover, because RNA interference led to 90% inhibition of hnRNP-E1 mRNA (without significant effects on hnRNP-E2 (11)), and the measured degradation rate of hnRNP-E1 had a t½ of over 48 h, we confirmed the effect of RNA interference against hnRNP-E1 mRNA on hnRNP-E1 protein by measuring a reduction in the rate of biosynthesis of newly synthesized hnRNP-E1 protein (Fig. 5) . Then we evaluated the effects of this RNA interference on altered HPV16 L2 and L1 mRNA in (HPV16)BC-1-Ep/SL-LF cells, which afforded an assessment of the direct connection between hnRNP-E1 protein and HPV16 L1 and L2 mRNA. We found that following reduction of hnRNP-E1 mRNA and protein, there was a progressive increase (reflecting a release following disinhibition) of HPV16 L1 and L2 mRNA levels as a function of days following RNA interference Fig. 5 . The relatively greater increase of HPV16 L2 mRNA when compared to L1 mRNA following RNA interference of hnRNP-E1 mRNA was the converse of combined inhibitory effects of homocysteinylated-hnRNP-E1 on both the HPV16 L2 RNA and 57-nucleotide poly(U)-rich ciselements.
The availability of a purified cell line of HPV16-harboring BC-1-Ep/SL cells-that could be propagated long-term as monolayers (12) in defined high-folate versus low-folate media without changes in the doubling-time of cells or spontaneous differentiation, and which had the ability to measure HPV16 early and late RNA in these cells-provided an unprecedented opportunity to mechanistically study the effect of hnRNP-E1 on HPV16 L1 and L2 RNA and proteins. However, to better define the physiological role of the HPV16 RNA interaction with homocysteinylated-hnRNP-E1, we stimulated (HPV16)BC-1-Ep/SL cells to develop into HPV16-organotypic rafts in which the entire HPV16 cycle is operative (12) . We determined that folate deficiency had a similar influence on HPV16 viral capsid proteins in HPV16-low folateorganotypic rafts as noted with keratinocyte monolayers (Fig. 6) . Moreover, the presence of a similar HPV16 DNA viral load in 18-day old HPV16-organotypic rafts developed in either highor low-folate media predicted less 55 nm HPV16 viral particles; this was confirmed on electron microscopy. However, the existence of high-level integration of HPV16 DNA into the genome of HPV16-low folate-organotypic rafts was unexpected and begs an explanation. There were two potential variables that could have influenced these findings: First, in HPV16-low folate organotypic rafts, there was a relative overabundance of amplified HPV16 DNA that could not be encapsidated into authentic HPV16 viral particles to complete the HPV16 life cycle (because of reduced HPV16 L1 and L2 viral capsid proteins). It is therefore possible that these apparently 'capsid-less' HPV16 DNA, with no 'escape route' out of the cell, could have somehow integrated into genomic DNA. Second, it is well known that folate deficiency inhibits thymidylate synthase, which leads to lowered deoxythymidine monophosphate synthesis and accumulation of deoxyuridine monophosphate (37) . This higher deoxyuridine monophosphate to deoxythymidine monophosphate ratio leads to increased misincorporation of deoxyuridine triphosphate into DNA by DNA polymerase (38) (39) (40) (41) . Although increased uracil misincorporation into DNA in folate deficiency (37, 38, (41) (42) (43) leads to removal by uracil-DNA glycosylase (44) and refilling of the missing base by DNA polymerase β (45), with repetition over several cycles, multiple singlestrand nicks are introduced into DNA predisposing to chromosome breaks (46) that can contribute to an increased risk of cancer associated with folate deficiency (42, 47, 48) . In addition, folate deficiency can also lead to double-strand breaks in DNA, which are difficult to repair when the two nicks are close to one another (within 12 bp of each other) on opposite strands (49) . Collectively, such double-strand DNA breaks in folate-deficient cells predispose to the development of acentric chromosomes, DNA fragments, and micronuclei (46, 50) , and could have rendered folate-deficient tissues more permissive to the integration of HPV16 DNA. Distinguishing between these two distinct variables and defining the extent of their relative [independent] contribution to HPV16 DNA integration into HPV16-low folateorganotypic raft DNA is currently under study.
In order to define the long-term consequences of high-level HPV16 DNA integration into folate-deficient HPV16-organotypic rafts warranted study in an animal model; however, there were no established models related to implantation of such rafts. Infection of human foreskin by oncogenic HPV that is implanted into immunodeficient mice has nevertheless been used in the past to confirm the role of HPV in growth promotion. However, none of these earlier models actually led to high-grade malignancy in the host. For example, implantation of HPV16-infected human foreskin implanted in immunodeficient mice has only led to the formation of papillomas, not to high-grade cancer (18) . While these models used SCID or Athymic Nude mice, because Beige Nude XID mice are severely immunodeficient, we determined if the latter were more likely to support the development of a malignancy provided another co-factor (like folate deficiency) was also present. So we tested whether the added variable of folate deficiency could tip the balance in favor of developing a cancer out of HPV16-low folate-organotypic rafts implanted subcutaneously in these mice. The transformation of benign 18-day old HPV16-low folate-organotypic raft-tissue into an aggressive malignancy within only 12 weeks in Beige Nude XID mice supports the likelihood that folate deficiency is a co-factor in HPV16-induced carcinogenesis. These findings raise additional questions on three interrelated issues: these include the importance of HPV16 DNA integration into the genome and carcinogenesis; the locus of integration into the host DNA; and the relationship of genomic DNA instability with folate deficiency (42) . Although it is controversial as to whether HPV DNA integration is a critical event in HPV-induced carcinogenesis clinically (51), integration does disrupt the viral regulatory gene E2; this, in turn, interferes with negativefeedback control of oncogene expression and leads to increased stability of E6 and E7 mRNAs (52) and a selective growth advantage of these cells (53) . Several studies have documented that the locus of integration of HPV16 DNA within the human genome is frequently found within common fragile sites (54) (55) (56) . While the majority of rare fragile sites in genomic DNA are induced by folate deficiency (57) (58) (59) (60) , among the common fragile sites, the one at 3p14.2 (FRA3B)-the most sensitive site on normal human chromosomes and which also contains a spontaneous HPV16 integration site (54)-as well as several other common fragile sites can also develop gaps and breaks when DNA replication is perturbed by "folate stress" (involving depletion of cellular deoxynucleotide pools by either folate deficiency or methotrexate) (54, (60) (61) (62) . Because there is direct evidence for the coincidence of viral integration sites and fragile sites (54) , it is possible that HPV16-low folate-organotypic rafts contained integration of HPV16 DNA into these [folatesensitive or 'folate stressed'] fragile sites in genomic DNA. With regard to the timing of HPV16 integration, Peitsaro et al (16) have identified that integration of HPV16 DNA into the host genome can occur early in the course of HPV16-induced cervical dysplasia; this parallels our finding of high-level integration HPV16 DNA in the cellular DNA of 18-day old HPV16-low folate-organotypic rafts. It is still unclear whether women infected with HPV16 who have clinical folate deficiency-(or vitamin-B 12 deficiency which also induces a functional intracellular folate deficiency (63))-have a greater extent of HPV16 DNA integration into the genomic DNA. This will be the focus of future clinical translational studies.
As suggested recently (11), the existence of accessible cysteine residues within KH-or RNA-recognition domains among other hnRNP family members and RNA-binding proteins, respectively, would likely be the primary determinant as to whether there is homocysteinylation of additional hnRNPs within folate-deficient cells; this would result in the coactivation of several additional nutrition-sensitive posttranscriptional RNA operons during clinical folate-and/or vitamin-B 12 -deficiency. One strong candidate for homocysteinylation includes hnRNP-E2 (also called CP2, or poly(C)-binding protein 2; PCBP2), which has 93% identity in the mRNA-binding KH domains with hnRNP-E1, and 100% identity in the position of cysteine residues within the three KH-domains (that are amenable for interaction with homocysteine) (11) . Acting together, these (and other homocysteinylatedhnRNP-activated) posttranscriptional RNA operons would comprise a novel, higher-order, nutrition-sensitive,
[homocysteine-responsive], posttranscriptional RNA regulon (64) that could have diverse effects on cellular and as well as on viral genes. In addition, apart from HPV16, homocysteinylated-hnRNP-E1 and -hnRNP-E2 may also bind to homologous RNA sequences in other benign and oncogenic HPV types, thereby potentially influencing their expression of late viral capsid proteins and infectivity of these viruses (65, 66) . Furthermore, there could be additional effects on other viruses: For example, the binding of hnRNP-E1 to the 5′-terminal clover-leaf structure of poliovirus RNA which facilitates interaction with the viral protein 3CD, a precursor of protease 3C and RNA polymerase 3D, promotes viral RNA replication (25, 67) . Blyn et al. (68) have also demonstrated that hnRNP-E2 is an essential factor that is required for efficient translation of poliovirus RNA. Such interactions of homocysteinylated-hnRNP-E1 and -hnRNP-E2 with the poliomyelitis cis-element would lead to increased binding and augment viral proliferation during clinical poliomyelitis in developing countries, where hyperhomocysteinemia (due to nutritional folate-and/or vitamin-B 12 -deficiency) is widely prevalent (63, (69) (70) (71) , and sporadic poliomyelitis is still an important public health problem. Significantly, Woolaway et al. (34) have also shown that both hnRNP-E1 and hnRNP-E2 have a modulating role on human immunodeficiency virus-1 (HIV-1); however, they elicit different responses as only overexpression of hnRNP-E1 inhibited the expression of several HIV-1 genes. Collectively therefore, our study predicts that HPV16, poliomyelitis, and HIV-1 RNAs are members of this posttranscriptional nutrition-sensitive RNA operon that is modulated by homocysteinylated-hnRNP-E1 [and likely hnRNP-E2]. Because there are hundreds of millions of individuals in the developing world with nutritional deficiencies of folate and/or vitamin-B 12 (10, 63, 70, 72, 73) , the net effect of these deficiencies on the natural history of HPV16, poliomyelitis, and HIV-1 infections, is an important new area for urgent study.
In summary, this work provides molecular evidence of a link between folate deficiency and HPV a full thirty years after an association was first suggested (74, 75) -[and further reinforced in the ensuing years by several epidemiologic studies that have also suggested an adverse role for hyperhomocysteinemia (76) (77) (78) (79) (80) (81) ]. Our studies predict that clinical nutritional folate-and/or vitamin-B 12 -deficiency a), will activate the nutrition-sensitive posttranscriptional RNA operon orchestrated by hnRNP-E1; b), will have a negative impact on generation of authentic HPV16 virions and alter the natural history of HPV16-induced infection; and c), will likely adversely influence the oncogenic transformation of epithelial dysplasia to cancer by facilitating HPV16-integation into unstable genomic DNA. Further evaluation among populations where both HPV16-induced cervical dysplasia and cancer as well as the deficiency of folate/vitamin-B 12 is common (63, (69) (70) (71) will help to clarify whether these micronutrient deficiencies are bona fide cofactors in the clinical transformation of HPV16-infected tissues to cancer. B, CAT activity from (HPV16)BC-1-Ep/SL-LF cells that were transfected with either pCAT or p57nt+CAT plasmids, following which cells were abruptly transferred to high-folate media and CAT activity was determined as a function of time.
C, CAT activity from (HPV16)BC-1-Ep/SL-HF cells transfected with either pCAT or p57nt+CAT plasmid DNA. After 48 h incubation in high-folate media, cells were exposed to increasing concentrations of L-homocysteine for 2 h and then assessed for CAT activity.
D, Expression of CAT mRNA in (HPV16)BC-1-Ep/SL-HF cells that were transfected with either pCAT or p57nt+CAT plasmid DNA, and then exposed to increasing concentrations of L-homocysteine. A, (HPV16)BC-1-Ep/SL-LF cells were transfected with either scrambled control RNA, (open bar) or siRNA against hnRNP-E1 mRNA (shaded bars) and harvested at 1, 2, and 3 days after transfection for RNA purification and qRT-PCR to determine the mRNA level of hnRNP-E1 (A), and HPV16 E6, E7, L1, and L2 (C). The data using scrambled RNA is expressed as 100 percent and was unchanged over 3 days, and data on inhibited hnRNP-E1 mRNA or other HPV related RNA is expressed as a percent of control values; the # symbol signifies the 100% control value. The maximum inhibition of hnRNP-E1 mRNA on the first day was consistently confirmed on 4 independent occasions. E-F, Determination of HPV16 E6 DNA (E) and HPV16 E7 DNA (F) viral load from HPV16-high folate-organotypic rafts (light shaded bars) and HPV16-low folate-organotypic rafts (dark shaded bars).
G-J, Photomicrographs of electron microscopy frames from the uppermost layer of HPV16-high folate-organotypic rafts (G,H) and HPV16-low folate-organotypic rafts (I,J) at lower magnification of X4800 (G, I) and higher magnification of X68,000 (H, J). Clumps of HPV16 viral particles are identified by arrowheads in G and I; one of these clumps in G and I identified by a boxed square is shown in higher magnification of X68,000 in H and I, respectively. The magnification and scale in each of these frames are shown in the top. Note that HPV16-low folate-organotypic rafts contained smaller clumps of HPV16 viruses, and overall less numbers of 55 nm HPV16 viruses per clump on higher magnification frames.
K-M, Comparison of HPV16 E6 and E2 DNA ratios as a reflection of the extent of integration of HPV16 DNA into the genomic DNA of rafts in HPV16-high folate-oganotypic rafts and HPV16-low folate-organotypic rafts (K and L). The amount of integrated HPV16 E6 DNA was calculated by subtracting the copy number of HPV16 E2 episomal DNA from the total copy number of HPV16 E6 DNA (episomal and integrated). The percentage of HPV16 DNA that was integrated into genomic DNA was then determined by dividing the integrated HPV16 E6 DNA copy number by total HPV16 E6 DNA copy number, and the result multiplied by 100 (M). A, Photograph of a Beige Nude XID mouse at 12 weeks following the subcutaneous implantation of a fragment obtained from an HPV16-low folate-organotypic raft. After steadily increasing to 2 cm 3 by the 14 th week, the tumor rapidly enlarged to 10 cm 3 in the ensuring 10 days, mandating euthanasia. There was no growth of HPV16-organotypic rafts propagated in either low-folate or high-folate amongst the other two species of Athymic Nude or SHrN TM SCID mice. B, Histological section of the primary tumor from (A) stained with hematoxylin-eosin that highlights significant angiogenesis within a population of cells with a high nuclear-cytoplasmic ratio, suggesting an underlying malignancy. Magnification was X44.
C,D, Clumps of HPV16 viral particles within the primary tumor (C); the area in the blue square is further magnified to demonstrate the presence of 55 nm size HPV16 viral particles (D).
E, Photograph of an aggressive tertiary tumor that developed within 2 weeks in a SHrN™ SCID mouse following the subcutaneous implantation of a small fragment from a secondary tumor that developed in Athymic Nude Mice which was earlier implanted with a fragment of the primary tumor in the Beige Nude XID mouse in (A).
F, Determination of growth pattern of four tertiary tumors that developed in SHrN™ SCID mice. The data is plotted as tumor volume as a function of time following subcutaneous implantation.
G, Western blots to determine the presence of HPV16-specific proteins within the primary tumor in the Beige Nude XID mouse (lane 1), as well as from secondary tumors from another Beige Nude XID mouse (lane 2) and an Athymic Nude mouse (lane 3). Note the presence of HPV16 E6, E7, L1 and L2 proteins in all tumors. There was no signal using an unrelated antiserum (data not shown).
H, Histological section of a secondary tumor stained with hematoxylin-eosin that highlights a monotonous population of malignant cells which exhibited a high nuclear-cytoplasmic ratio, open chromatin, and several cells captured at various stages of replication. Magnification was X100. by guest on October 5, 2017 
